You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-active secondary progressive MS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Glostrup, Copenhagen, Denmark
  • +11 more
May 3, 2022

Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

Recruiting
  • Secondary-progressive Multiple Sclerosis
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Oct 10, 2022

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

Withdrawn
  • Primary Progressive Multiple Sclerosis
  • +2 more
  • Intranasal Foralumab Solution
  • Placebo
  • (no location specified)
Feb 14, 2022

Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

Recruiting
  • Progressive Multiple Sclerosis
  • Placebo
  • Masitinib (4.5)
  • Lille, France
  • +1 more
Jul 1, 2022

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Metformin Hydrochloride 850 mg Oral Tablet
    • Placebo
    • Brugge, Belgium
    • +4 more
    May 30, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Multiple Sclerosis Trial (Siponimod)

    Available
    • Multiple Sclerosis
    • (no location specified)
    Sep 13, 2022

    Multiple Sclerosis Trial (Ocrelizumab Injection [Ocrevus])

    Not yet recruiting
    • Multiple Sclerosis
    • Ocrelizumab Injection [Ocrevus]
    • (no location specified)
    Aug 22, 2023

    Measuring Active Microglia in Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
    • [C11]PK-1195 PET scan
    • New York, New York
      Weill Cornell Medical College
    Jan 14, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

    Recruiting
    • Active Secondary Progressive Multiple Sclerosis
    • siponimod
    • Ancona, AN, Italy
    • +19 more
    Dec 27, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2021

    Multiple Sclerosis Trial in New York (Active RS-tDCS +At-Home Manual Dexterity Training, Sham RS-tDCS +At-Home Manual Dexterity

    Completed
    Has Results
    • Multiple Sclerosis
    • Active RS-tDCS +At-Home Manual Dexterity Training
    • +2 more
    • New York, New York
      New York University School of Medicine
    Feb 11, 2022

    Mayzent on SPMS Patients in a Long-term Non-interventional Study

    Recruiting
    • Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
    • Siponimod
    • Baden, Aargau, Switzerland
    • +8 more
    May 16, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

    Completed
    Has Results
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Dublin, Dublin 4, Ireland
    • +1 more
    Jul 8, 2021

    MS - a Prospective Cohort Study

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • PASS-MS
    • Berlin, Germany
      Experimental and Clinical Research Center, Studienambulanz Neuro
    Aug 9, 2021

    Imaging Interplay Between Axonal Damage and Repair in Multiple

    Recruiting
    • Multiple Sclerosis (MS)
    • +3 more
    • MRI
    • +2 more
    • Basel, Switzerland
      University Hospital Basel, Department of Neurology
    Dec 15, 2021

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

    Active, not recruiting
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • ATA188
    • Placebo
    • La Jolla, California
    • +33 more
    Jul 21, 2022

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Primary Progressive Aphasia, Logopenic Progressive Aphasia, Non-Fluent Primary Progressive Aphasia Trial in Baltimore,

      Not yet recruiting
      • Primary Progressive Aphasia
      • +2 more
      • Active tDCS + Language Therapy
      • Sham tDCS + Language Therapy
      • Baltimore, Maryland
      • +2 more
      Dec 14, 2022

      Logopenic Variant Primary Progressive Aphasia, Non-Fluent Primary Progressive Aphasia Trial in Boston (Active rTMS, SHAM rTMS)

      Completed
      • Logopenic Variant Primary Progressive Aphasia
      • Non-Fluent Primary Progressive Aphasia
      • Active rTMS
      • SHAM rTMS
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 6, 2022

      Logopenic Variant Primary Progressive Aphasia, Non-fluent Variant Primary Progressive Aphasia, Semantic Variant Primary

      Recruiting
      • Logopenic Variant Primary Progressive Aphasia
      • +2 more
      • ACTIVE rTMS
      • SHAM rTMS
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 4, 2022